Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 335

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey

Ghosh, Subrata, Mitchell, Rod · 2007 · Journal of Crohn's and Colitis

Abstract

BACKGROUND: : The predominant symptoms of inflammatory bowel disease (IBD) are diarrhoea, abdominal pain, gastrointestinal bleeding, weight loss, malnutrition and fatigue. These symptoms can have substantial psychosocial implications and cause sufferers to limit their lifestyles, with consequent impact on quality of life (QoL). AIMS: : To survey the impact of IBD on peoples' lives as well as opinions of treatment and patient-doctor communication in a large European cohort of patients. SUBJECTS AND METHODS: : Seven organisations affiliated with the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) distributed questionnaires to 12,200 members between May and August 2005. In total, 5636 responses were received and analysed using descriptive statistics. RESULTS: : Of 5576 patients with evaluable responses, 1000 (17.9%) were not currently receiving any treatment, and 3109 (55.8%) were currently receiving anti-inflammatory/5-aminosalicylic acid, 1143 (25.9%) receiving immunomodulators, and 1076 (19.3%) receiving steroids (biologics constituted 4%; however, at the time of this survey they were not approved for use in treating patients with UC). Three quarters were either very (n=2233, 40.0%) or somewhat (n=2010, 36.0%) satisfied with the results obtained from their current treatment medication. If given a choice, 4819 (86.4%) said they would rather try a new type of drug therapy than undergo surgery. However, only 2182 (39.1%) reported that their doctor talked to them about newly developed treatments. Three quarters (75.6%, n=4213) reported that symptoms affect their ability to enjoy leisure activities, while over two thirds (68.9%, n=3841) felt symptoms affected their ability to perform at work. However, nearly half (n=2666, 47.8%) reported that their doctor does not ask about the impact of symptoms on their QoL. For those patients who received immunomodulators, 72.7% reported QoL improvements (1462/2012) while 72.8% reported QoL improvements with steroids (2622/3601). 75% of patients with CD who received biologic therapy (6% of responders) stated that their QoL improved following biologic therapy. CONCLUSIONS: IBD symptoms have a substantial impact on patients' lives, and QoL as well as new treatments should be an important feature of patient-physician discussions. The survey results may point to areas where support of IBD patients might be improved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.crohns.2007.06.005

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 335

Metadata

Authors
Ghosh, S., & Mitchell, R.
Venue
Journal of Crohn's and Colitis
Published
2007-09
Volume
1
Issue
1
Pages
10-20
ISSN
1873-9946 (ISSN-L)
OpenAlex
W1988604248
Cited by
335
References
25
FWCI
2.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. https://app.cochat.ai/papers/10.1016/j.crohns.2007.06.005
The paper
Ghosh, S., & Mitchell, R. (2007). Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. Journal of Crohn's and Colitis. https://doi.org/10.1016/j.crohns.2007.06.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.